Rockfish Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- (Upcoming)
- Latest Deal Amount
-
$11.6M
- Investors
-
5
Rockfish Bio General Information
Description
Developer of senolytic compound-based therapies intended to treat age-related diseases and disorders. The company specializes in specifically effective methods for eliminating senescent renal epithelial cells with a therapeutic index of up to seven hundred, enabling medical professionals to treat chronic diseases and improve the quality of life by promoting healthy aging.
Contact Information
Website
www.rockfishbio.comCorporate Office
- Leberstrasse 20
- Vienna, 1110
- Austria
Corporate Office
- Leberstrasse 20
- Vienna, 1110
- Austria
Rockfish Bio Timeline
Rockfish Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | $11.6M | Upcoming | Pre-Clinical Trials | |||
| 4. Grant | 03-Jun-2025 | Completed | Startup | |||
| 3. Seed Round | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 17-Nov-2021 | $693K | $693K | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2021 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rockfish Bio Patents
Rockfish Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025242858-A1 | Composition for selective elimination of senescent cells | Pending | 23-May-2024 |
Rockfish Bio Signals
Rockfish Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Rudolf Sallinger Fonds | Other | |||
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| red-stars.com data | Holding Company | Minority | ||
| Medical University of Vienna | University | |||
| University of Natural Resources and Life Sciences, Vienna | University |
Rockfish Bio FAQs
-
When was Rockfish Bio founded?
Rockfish Bio was founded in 2021.
-
Where is Rockfish Bio headquartered?
Rockfish Bio is headquartered in Vienna, Austria.
-
What is the size of Rockfish Bio?
Rockfish Bio has 5 total employees.
-
What industry is Rockfish Bio in?
Rockfish Bio’s primary industry is Drug Discovery.
-
Is Rockfish Bio a private or public company?
Rockfish Bio is a Private company.
-
What is Rockfish Bio’s current revenue?
The current revenue for Rockfish Bio is .
-
How much funding has Rockfish Bio raised over time?
Rockfish Bio has raised $2.66M.
-
Who are Rockfish Bio’s investors?
Rudolf Sallinger Fonds, Austria Wirtschaftsservice, red-stars.com data, Medical University of Vienna, and University of Natural Resources and Life Sciences, Vienna have invested in Rockfish Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process